Internal Medicine · Loma Linda, CA
NPI
1518145499
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
11234 Anderson St, Cp 21005
Loma Linda, CA, 92354
Phone (909) 824-0800
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
749 services
Medicare patients, 2024
20
Average age 66
Drug cost, 2024
$4.3M
1,952 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Mie Mie Thinn prescribed most often to Medicare patients was Anastrozole, with 227 prescriptions and refills. In total Mie Mie Thinn wrote 1,952 Medicare prescriptions that cost $4.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 227 | 676 | 72 | $6,313 |
| Abiraterone Acetate Generic | 144 | 146 | 24 | $21K |
| Prednisone Generic | 141 | 184 | 40 | $1,111 |
| Ondansetron Hcl Generic | 100 | 100 | 39 | $841 |
| Dexamethasone Generic | 93 | 100 | 30 | $1,099 |
| Letrozole Generic | 87 | 261 | 30 | $1,769 |
| Lenalidomide Generic | 76 | 76 | Under 11 | $958K |
| Gabapentin Generic | 75 | 137 | 23 | $1,196 |
| Potassium Chloride Generic | 69 | 85 | 26 | $853 |
| Hydroxyurea Generic | 61 | 142 | 17 | $1,979 |
| Omeprazole Generic | 41 | 118 | 20 | $370 |
| Acyclovir Generic | 40 | 53 | Under 11 | $634 |
| Allopurinol Generic | 38 | 78 | 11 | $357 |
| Xtandi Enzalutamide | 32 | 32 | Under 11 | $391K |
| Pradaxa Dabigatran Etexilate Mesylate | 30 | 44 | Under 11 | $4,334 |
Brand drugs: - claims; generic drugs: 1,608 claims; opioid claims: 35.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Mie Mie Thinn were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.